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Introduction
Upper endoscopy, or esophagogastroduodenoscopy (EGD), is a
commonly performed procedure allowing for direct visualiza-
tion (diagnostic) and interaction (therapeutic) with mucosal
surfaces of the esophagus, stomach, and first part of the small
intestine. Common indications include evaluation of gastroin-
testinal bleeding, dysphagia, gastroesophageal esophageal re-
flux disease (GERD) non-responsive to medical therapy, esoph-
ageal varices screening, and anemia [1]. The utility of EGD in
the evaluation and management of many upper gastrointesti-
nal (UGI) conditions has made it an integral part of patient care.
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Background and study aims Our academic lab has devel-
oped a novel, low-cost, disposable endoscope for assess-
ment of the esophagus and stomach without need for large
equipment or complex electronics. Usability and intuitive-
ness of the platform are unknown.
Methods The novel endoscope (NE) consists of a high-de-
finition camera, LED module, and three bellows. Compres-
sed air actuates the bellows, producing camera/LED articu-
lation. Insufflation and lens cleaning ports are present. Vid-
eo can be displayed on any monitor. Total material costs
less than $35 US. Five novices, five fellows, and five attend-
ings performed five trials using a conventional endoscope
and the NE on an upper tract phantom with six gastric land-
marks marked. Outcomes included successful identification
and time to landmarks; and intuitiveness (NASA task load
index; user comments).
Results All landmarks were successfully identified with
both endoscopes for all trials (n =900). Attendings and fel-
lows were quicker with the conventional endoscope when
compared to the NE (24.48 v 37.13s; P <0.01). There was
no significant time difference between platforms for novi-
ces (P=0.16). All users found the NE intuitive with low men-
tal and physical demand. Novices reported lower temporal
demand and effort when using the NE.
Conclusions The NE was easy to maneuver, intuitive, and
successful at visualizing gastric landmarks. All users were
pleased with the NE drive mechanism and were successful
at visualizing the gastric landmarks in a clinically acceptable
time. The novel platform has the potential to facilitate ra-
pid, low-cost, diagnostic assessment of the esophagus and
stomach in non-traditional settings – facilitating patient
management decisions, minimizing encumbrance, and
avoiding cross-contamination.
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Unfortunately, despite the large number of EGDs performed
annually in the world, access to the procedure remains limited
as EGD is typically performed in specialized centers (ambula-
tory surgery centers) and select locations within a hospital
(endoscopy lab, intensive care unit [ICU], emergency depart-
ment [ED]). The main reasons for these limitations relate to
the need for sedation (which requires monitors, intravenous,
rescue equipment, oxygen, staff, recovery time) and large,
cumbersome, expensive, bulky equipment (endoscopy light
source and processor, endoscope, monitor, cables, cart, com-
puter) with intricate handling, maintenance, and reprocessing
facilities as current standard. Sedation-related adverse events
(AEs) – including hypoxemia, hypotension, and aspiration
pneumonia – are the most common complications associated
with endoscopy (making up 60% of all EGD AE) [2]. In addition,
conventional EGD requires reprocessing of equipment with risk
of cross-contamination or infection. Each used endoscope un-
dergoes leak testing, manual cleaning, high-level disinfection,
and repairs if indicated, with an estimated cost ranging from
$114 to $280 per use [3]. Another limitation to EGD access is
the relative shortage of providers able to perform the proce-
dure, especially in rural and remote locales, due to need for spe-
cialized training in order to perform the procedure successfully
– as a significant amount of time is dedicated to mastering both
the technical and cognitive aspects [4].
To overcome these limitations and facilitate a potential para-
digm shift in gastrointestinal endoscopy, our team has devel-
oped a novel, low-cost, disposable, portable, intuitive platform
for diagnostic upper endoscopy that potentially can be used
off-the-shelf, at the bedside, in non-traditional settings (i. e.
primary care office, hepatology clinic) and in the hospital to fa-
cilitate efficient triage and patient care – thereby leaving con-
ventional upper endoscopy, as we currently know it, to tissue
sampling and therapy. Our system uses direct mechanical cou-
pling between a mechanical joystick and a pneumatically actu-
ated endoscopic tip, allowing for intuitive handling and manip-
ulation that may permit rapid, low-cost, bedside visualization
of the esophagus and stomach by a variety of healthcare provi-
ders without a long technical learning curve [5]. System func-
tionality, effectiveness in visualizing key gastric landmarks, in-
tuitiveness of the drive mechanism, and user satisfaction in a
human phantom, as a step toward first-in-human use, remains
unknown.
The aim of this study was two-fold. First, we aimed to assess
if our novel platform provided enough range of motion at the
distal tip to allow for successful visualization of key gastric land-
marks. Second, we aimed to quantify and compare ease of use





The novel esophago-gastroscope (▶Fig. 1a) is composed of a
13.5-mm-diameter clear tip (Clear V3, FormLabs, Inc., Somer-
ville, Massachusetts, United States) (▶Fig. 1b) that embeds a
1280×1024-pixel high-definition camera for imaging and three
light-emitting diodes (LEDs) for illumination of the esophagus
and stomach. The tip is then connected to three rubber bellows
(BC-2305, rubberstore.com, Vandalia, Ohio, United States) ar-
ranged in parallel (▶Fig. 1b) and attached to ports in a 7-mm-
diameter highly compliant, flexible, seven-lumen catheter. The
catheter allows for wiring, irrigation/lens cleaning, lumen insuf-
flation, and pressurization of the bellows from the operating
handle. The operating handle is a multi-backbone continuum
joystick (▶Fig. 1c) [6, 7] with four embedded Nitinol wires
within six plastic disks separated by springs – one centrally lo-
cated (referred to as the primary backbone) and three equally
spaced around it (referred to as the secondary backbones).
This structure terminates in a pivoting pad. The novel endo-
scope weighs a total of 0.56Kg and when produced en-masse
has an inclusive cost of approximately 32 USD per endoscope
(▶Table 1).
The drive mechanism for the novel endoscope is character-
ized by direct mechanical coupling between the continuum joy-
stick and the steerable tip. This is achieved by pneumatic actua-
tion via a mechanism known as a Parallel Bellow Actuator (PBA)
[8, 9]. As the joystick is manipulated about the pivoting pad,
the free ends of the secondary backbones elongate and retract.
By coupling the free ends with three 10-cc syringe pistons, em-
bedded in the device handle (▶Fig. 1c), motion is converted to
bellow pressurization and depressurization. Variation in pres-
sure directly corresponds to change in bellow length – yielding
three degrees of freedom: (1) tilting angle, (2) angle of the tilt-
ing plane, and (3) elongation/retraction (▶Fig. 2). This, in turn,
directs the tip in a configuration commensurate to the joy-
stickʼs input configuration.
Similar to a conventional endoscope, the device is operated
using one hand to steer the tip and the other for inserting or re-
moving the insertion tube/catheter. The device is designed for
ambidextrous use (i. e. it is not hand-specific) as the handle is
maneuvered about the pivoting pad secured against the opera-
tor’s body (▶Fig. 1a).
Ten AA batteries power the system and video is transmitted
to the operator’s personal device (i. e. mobile phone, tablet, TV,
computer monitory) via a secure local Wi-Fi feed (novel endo-
scope directly to the personal device). Insufflation, irrigation,
and lens cleaning are operated via quick-connect port and 60-
cc syringe (▶Fig. 1a).
Phantom
A human stomach and esophagus phantom was created from
the computed tomography scan images of a 70-kg adult male
patient. The images were extracted and reconstructed to serve
as a 3D printed mold (Ultimaker Inc, Geldermalsen, Nether-
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lands). Silicone was then placed in layers to construct the phan-
tom (EcoFlex 00-30, SmoothOn, Macungie, Pennsylvania, Uni-
ted States) (▶Fig. 3). Ultra-low power LEDs were placed at key
anatomic locations within the molded stomach as it was con-
structed to serve as consistent markers of gastric landmarks. A
total of six anatomic landmarks were affixed: gastroesophageal
junction (GEJ), fundus, body greater curvature (GC), body les-
ser curvature (LC), antrum GC, and antrum LC. LED activation
was controlled by an embedded micro controller (Arduino
Mega 2560, Turin, Italy) connected via USB to a dedicated
data-recording computer (OptiPlex 390, Dell, Round Rock,
Texas, United States) that allowed the LEDS to be turned on
and off during the trial. The phantom was encased in a wood
support structure to prevent participant visualization of the
landmarks or phantom externally.
Study design
A total of 15 participants were selected to perform endoscopy
in the stomach and esophagus phantom. The participants were
selected from our tertiary care medical center by email and
face-to-face encounters. Five gastroenterology attendings
(> 1000 lifetime conventional upper endoscopies), five gastro-
enterology fellows (postgraduate year (PGY) 4–6), and five no-
vices (PGY 1 internal medicine residents who had never handled
an endoscope) were enrolled. Each user performed endoscopic
examination of the GEJ and stomach with the conventional up-
per endoscope (Karl Storz, Tuttlingen, Germany) and with the
novel disposable endoscope. Each participant performed a total
of 10 examinations using both devices in random order (con-
ventional n=5; novel n=5; 1:1 fashion). Examination was per-
formed in a gastroenterology outpatient clinic examination
room (▶Fig. 4). Each user was given a 1-minute practice period
▶ Fig. 1 The novel disposable flexible endoscope a with close-up view of the tip b and handle c (handle cover has been removed to allow
visualization of the internal components).
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with the conventional endoscope and novel endoscope the first
time it was selected. The practice period was performed out-
side of the phantom. After this minute, the user introduced
the endoscope into the phantom and positioned the tip in the
distal esophagus, 5 cm from the GEJ. The anatomic landmark
LEDs were then illuminated and the user was tasked with iden-
tification of all six gastric landmarks (▶Fig. 5). Successful iden-
tification of the landmark was denoted by en-face visualization
with the endoscope and verbally communicating the color of
the LED to the study staff. The time of identification was record-
ed and the LED was turned off. The exam was considered com-
plete when all six landmarks were successfully identified or if a
time >10 minutes was reached. ▶Fig. 6 summarizes the proto-
col adopted for the study.
After all 10 exams were performed, each participant com-
pleted a validated assessment instrument for each device used
(NASA Task Load Index v1.0; NASA Ames Research Center, Mof-
fett Field, California, United States) and assigned an overall sa-
tisfaction score [10]. The NASA Task Load Index (TLX) is com-
posed of six scales: mental demand (how mentally demanding
was the task), physical demand (how physically demanding was
the task), temporal demand (how hurried or rushed was the
pace of the task), performance (how successful were you in ac-
complishing what you were asked to do), effort (how hard did
you have to work to accomplish your level of performance),
and frustration (how insecure, discouraged, irritated, stressed,
▶ Table 1 Novel endoscope component cost based on large-scale
production.
Component Price (USD)
Plastic parts $ 7.00
Multi-Lumen catheter $ 1.10
Wiring $1.50
Bellows (3) $ 6.00
Syringes (3) $ 1.00
Camera and LED $7.50
Nitinol wire $ 5.00
Screws and Standoffs $ 3.00
TOTAL $32.10
LED, light-emitting diode
▶ Fig. 2 The joystick and corresponding tip motion of the dispo-
sable flexible endoscope: a elongation, b retraction, c tilting
angle, d angle of tilting plane.
▶ Fig. 3 The human stomach and esophagus phantom with LED
marked anatomic landmarks.
▶ Fig. 4 Trial set-up. Conventional endoscope monitor a and tower
b; stomach and esophagus phantom c; novel endoscope and
monitor d; LED anatomic landmark controller e; computer for
recording of trial data f.
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and annoyed were you). All subscales range from 0 (very low) to
100 (very high) with the exception of performance, which
ranges from 0 (perfect) to 100 (failure). Each user was then
asked for non-structured qualitative feedback using open-
ended questions (what are your thoughts about the endoscope
[conventional; novel]?).
Study outcome and statistical analysis
The main outcome measure was successful identification of the
six gastric landmarks. Secondary outcomes included overall
time to perform gastric landmark visualization, ease of use
(TLX), and user comments. The time to visualize each individual
gastric landmark and the order in which they were visualized
was also recorded.
To detect differences in visualization time between devices
within each user group, a paired t test was used. To detect dif-
ferences in visualization time for a given device between the
three user groups, an ANOVA test was used. To compare the
variation in total time between experienced users of conven-
tional endoscopes when using the novel endoscope, prior data
indicated a standard deviation of the difference in time of 10
seconds. With 10 experienced users (5 fellows, 5 attendings)
performing five trials each with the novel endoscope, we had
90% power to detect a 5-second difference in time. To compare
the increase in time when novices used the novel endoscope,
prior data indicated a standard deviation of the difference in
time of 14 seconds. With 10 experienced users and five novices
performing five trials each with the novel endoscope, we had
▶ Fig. 5 Images of the stomach and esophagus phantom taken with the novel disposable endoscope. The distal esophagus a and gastric land-
marks (LED anatomic markers; b body greater curvature (blue); c antrum greater curvature (yellow) and body lesser curvature (purple); d an-
trum lesser curvature (green); e GEJ (red) and fundus (white) are visualized.
Enrollment
Consent and demographic information
Instruction
i = 0
i = i + 1
Randomization
Go to start location
TLX
Qualitative feedback, end






1 min practice period 
▶ Fig. 6 Flow diagram for the trial. Each user performed 10 endoscopies (conventional, n =5; novel, n =5) on the human phantom for identifi-
cation of the gastric landmarks.
Garbin Nicolò et al. Evaluation of a… Endoscopy International Open 2019; 07: E1175–E1183 E1179
90% power to detect a 6-second difference. All calculations as-
sumed the probability of type I error of 5%.
Lower, median, and upper quartile ranges were calculated
for continuous variables. A variable Z was utilized to assess for
differences in the order of landmark visualization for each trial.
We defined Z as:
Where m and n are the rows and columns of the landmarks-
order matrices, respectively; C identifies the landmarks-visuali-
zation order matrix when using the conventional endoscope; N
the landmarks-visualization order matrix using the novel endo-
scope; and C̄ and N̄ are the mean of all values of C and N, respec-
tively.
After completion of the trial, participants completed a vali-
dated TLX assessment instrument with overall satisfaction
score for each endoscope (conventional; novel) and provided
non-structured qualitative feedback by face-to-face interview.
All data was securely recorded using Research Electronic Data
Capture (REDCap) (Nashville, Tennessee, United States [11].
This study was approved by the medical center Institutional Re-
view Board before initiation of data collection (IRB#171660).
Results
Five attendings (mean number of lifetime procedures: 4800±
3000), 5 fellows (900±300), and 5 novices (0 ±0) completed
the trial. Three of the participants were women (20%) and one
of the participants was left-hand dominant (7%) (▶Table2). All
participants (n =15) successfully identified all six gastric land-
marks with the conventional endoscope and with the novel
endoscope for each trial (100%; n=900). The time to landmark
identification for all groups combined was shorter with the con-
ventional endoscope when compared to the novel endoscope
(18.07 v. 28.16 seconds; P<0.01). The total time for all trials
was normally distributed and there was no difference in time
to landmark identification for the novice group when compar-
ing the conventional endoscope to the novel endoscope
(27.99 v. 38.09 seconds; P=0.16). For attendings and fellows,
use of the conventional endoscope was quicker when com-
pared to use of the novel endoscope (13.82 v. 26.27 seconds;
P<0.01 and 17.7 v. 23.37 seconds; P=0.01 respectively) (▶Ta-
ble3). The maximum and minimum time to visualize all land-
marks was 113.07 and 5.04 seconds with the conventional
endoscope and 126.33 and 9.42 seconds with the novel endo-
scope. Using the conventional endoscope, attendings were
quickest when compared to the other groups (P<0.01). When
the novel endoscope was used, there was no difference in time
between user groups (attending, fellow, novice) (P=0.094).
▶Fig. 7 shows the lower, median, and upper quartile of both to-
tal time and specific landmark identification time for each
group of participants using both devices (conventional and no-
vel endoscope).
By recording (Supplementary Table1) the order in which
each landmark was identified with a specific device (conven-
tional/novel), we verified that the path taken to visualize the
landmarks was consistent for each user group using the two de-
vices (novel and conventional endoscope) – verifying that the
order of landmark visualization did not influence the results
(Z=0.948 [attendings], 0.923 [fellows] 0.907 [novices]).
All participants operated the novel endoscope successfully
despite having no prior experience or formal training outside
of the 1-minute practice period. The novel endoscope was reli-
able throughout each trial without video, electric, or mechani-
cal failure. Participants reported both low mental demand and
low physical demand (▶Table4). Five users specifically noted
intuitiveness of the novel endoscope (2 novices), ease of use
(1 fellow), or ease to learn (1 novice, 1 attending) in their user
▶ Table 2 Participants in the study.
Participants Women Age Lifetime # of endoscopic procedures Left-hand dominance
n (%) x±SD x±SD n (%)
Novice (n =5) 0 (0) 29 ±2.28 0 ± 0 0 (0)
Fellow (n =5) 1 (20) 31 ±0.89 900±300 0 (0)
Attending (n =5) 2 (40) 41 ±2.22 4800 ±3000 1 (20)
All combined (n = 15) 3 (20) 33 ±5.67 1900 ±2700 1 (6.66)
▶ Table 3 Total time to complete the task of identifying all six gastric landmarks. Medians [Q1, Q3].
Participant Conventional Novel P value
Novice (n =5) 27.99 s [18.07; 43.19] 38.09 s [15.17; 64.72] P=0.16
Fellow (n =5) 17.7 s [11.74; 20.94] 23.37 s [18.45; 35.1] P=0.01
Attending (n =5) 13.82 s [9.62; 19.56] 26.27 s [17.72; 41.7] P <0.01
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feedback comments (Supplementary Table2). Three users
specifically expressed satisfaction with the novel platform’s
low weight (1 novice, 1 attending, 1 fellow) and ergonomics (1
fellow) when compared to the conventional endoscope.
Discussion
The novel esophago-gastroscope was easy to maneuver, intui-
tive to use, and successful at visualizing key landmarks in the
stomach in a timely manner regardless of users having no prior
experience with the novel endoscope. While fellows and at-
tendings had longer mean times with the novel endoscope
when compared to the conventional endoscope, their times re-
mained within a clinically acceptable range (difference of ap-
proximately 10 seconds). This finding is likely due to the fel-
lows’ and attendings’ experience and comfort in using the con-
ventional endoscope – as the mechanism of the novel endo-
scope is inherently different from a conventional endoscope (i.
e. no need for insertion tube torque or thumb wheel manipula-
tion of Bowden cables).
In the novice group, without any endoscopy experience,
there was no such difference, suggesting that unbiased users
performed with essentially equal efficiency with both devices.
In addition, both experienced endoscopists and novices per-
formed well with the novel endoscope, suggesting a short
learning curve (supporting the intuitiveness of the novel plat-
form.) This portends well for potential efficacy in clinical sce-
narios for diagnostic upper endoscopy given our intended de-




















































▶ Fig. 7 Trial results by endoscope type (conventional; novel) and user (novice; fellow; attending). Total time and landmark specific identifica-
tion times are displayed (median = red circle; Q1Q3=blue line; F = fundus; A.LC= antrum lesser curvature; B.LC=body lesser curvature; A.GC=
antrum greater curvature; B.GC=body greater curvature; GE=gastroesophageal junction).
▶ Table 4 The NASA Task Load Index (TLX) subscale scores for the novel endoscope and conventional endoscopy by participant group. All subscales
range from 0 (very low) to 100 (very high) with the exception of performance, which ranges from 0 (perfect) to 100 (failure). Median [Q1, Q3].
Subscale Novice (n =5) Fellow (n=5) Attending (n=5)
Novel Conventional Novel Conventional Novel Conventional
Mental demand 32 [7, 62] 41 [23, 66] 45 [9, 51] 3 [1, 12] 27 [11, 51] 13 [5, 18]
Physical demand 17 [5, 49] 42 [10, 82] 20 [14, 47] 10 [2, 29] 13 [10, 41] 12 [5, 20]
Temporal demand 50 [35, 56] 63 [54, 76] 19 [12, 45] 4 [1, 35] 33 [13, 51] 23 [8, 35]
Performance 25 [10, 34] 37 [16, 59] 33 [26, 36] 20 [5, 51] 47 [07, 59] 17 [07, 33]
Effort 50 [22, 73] 67 [33, 80] 25 [9, 55] 20 [6, 39] 34 [20, 58] 7 [5, 13]
Frustration 74 [24, 76] 51 [48, 71] 16 [13, 55] 9 [1, 32] 42 [12, 54] 8 [3, 14]
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mographic of non-specialized users (i. e. non-traditional endos-
copists: ED providers, ICU physicians, primary care providers,
etc.). Users of the novel platform may not require extensive
technical training in traditional endoscopy in order to maneu-
ver the novel endoscope, and can instead focus their attention
on cognitive skill (i. e. recognition of “normal” or “abnormal”
findings to support triage decisions).
All participants in the study found the novel endoscope easy
to use and intuitive with low mental and physical demand. No-
vices had reduced temporal demand and effort with the novel
endoscope. While novices reported increased frustration with
the novel endoscope, this was primarily related to incidences
where the pivoting pad slipped and necessitated re-establish-
ment of pad contact with their body. While attendings and fel-
lows favored the conventional endoscope, novices favored the
novel endoscope. This is likely explained by the extensive ex-
perience with conventional endoscopy in the fellow and attend-
ing groups, who attempted to drive the novel endoscope as if it
were a conventional endoscope. Novices, who lacked any ex-
perience with either endoscope, preferred the novel endo-
scope. Regardless of endoscopy experience, all users were able
to complete the task with the novel endoscope in an efficient
manner and were pleased with the novel deviceʼs ergonomics,
low weight, and ease of manipulation (Supplementary Ta-
ble 2). This would suggest that the intuitive drive mechanism
is robust, effective, and functions well for the task at hand
(especially for those without any specialized conventional
endoscopy training).
Our results also suggest potential efficacy in clinical use,
pending further studies and minor design revisions. This is
especially significant given that the novel endoscope is low-
cost (less than $35 in materials; lower if produced on a large
scale), intuitive to drive without prior experience, and without
need for bulky equipment or device reprocessing. One could
imagine point-of-care management decisions being potentially
made in non-traditional settings (primary care provider office,
inpatient medical or surgical ward) at the initial encounter.
This could be possible with administration of a topical anes-
thetic agent given the current flexible catheter width of 7mm
(with plan to reduce the tip dimension to less than 8mm) with
pliability similar to currently used orogastric tubes. Similar to
other tools such as central line kits, providers would have the
potential to take the novel device “off-the-shelf,” open the
package, and perform their exam to triage the patient to con-
ventional endoscopy with intervention or another care plan. As-
suming that the novel endoscope is well tolerated after applica-
tion of a topical anesthetic and that the diagnostic capability
sufficiently facilitates reduced utilization of conventional upper
endoscopy, AEs could potentially be reduced and the risk/bene-
fit ratio for conventional upper endoscopy could be more ad-
vantageous if it were purely an interventional procedure.
Examples of this shift in work flow that could be possible
with appropriate training (technical and cognitive) for non-spe-
cialized users (i. e. to identify “normal” from “abnormal”) in-
clude a primary care provider seeing a patient in clinic with
long-standing GERD or GERD non-responsive to acid suppres-
sion medications, odynophagia, or suspicion of peptic ulcer or
gastrointestinal etiology for anemia. In this case, a primary
care provider could perform rapid bedside diagnostic examina-
tion of the patients’ stomach and esophagus. Identification of
any suspicious finding(s) (i. e. presumed Barrett’s esophagus,
esophageal stenosis, candida esophagitis, neoplasm, varices,
peptic ulcer) could then be sent for an expedited and directed
interventional upper endoscopy performed in the traditional
setting.
Another example, with appropriate training, could be
screening for esophageal and gastric varices in an outpatient
hepatology clinic for “point-of-care” diagnosis. As patients
with cirrhosis are at increased risk for sedation-related AEs,
avoidance of conventional upper endoscopy, unless necessary
to perform esophageal band ligation of varies, would be opti-
mal [12]. In the hospital setting (ED, inpatient ward, or ICU),
having immediate bedside diagnostic information, as in the
case of suspected gastrointestinal bleeding or foreign body,
would allow for prompt and accurate triaging of the patient
(i. e. need for gastroenterology consultation versus pulmonary,
interventional radiology, or ENT, admit or discharge from the
ED, expedited inpatient travel case, transfer to an ICU).
A potential limitation of our study is the small number of
participants from a single institution and single division (Gas-
troenterology). While we were able to detect a difference be-
tween the groups as intended based on the main outcome
measure and power calculation, future studies will include an
increased breadth of participants from multiple specialties
(pulmonologists, emergency medicine providers, primary care
providers, surgical), skill levels (PGY trainees in those special-
ties, mid-level providers, and attendings) and from multiple
centers with a formal learning curve assessment.
Another potential limitation was the practice period with the
conventional endoscope and the novel endoscope. To avoid po-
tentially jeopardizing or influencing the assessment of ease of
use, the time frame of 1 minute was selected. Our team felt
that if the practice period were longer, any difference between
the platforms that might exist might be undetectable. In addi-
tion, given the intended users of the novel platform (primary
care providers, ICU providers, emergency department provi-
ders), we aimed to demonstrate that use of the novel endo-
scope was intuitive with a short learning curve that required
no more than 1 minute of time to comprehend.
The path taken to visualize the landmarks had the potential
to significantly affect the results – if one order or path for visua-
lizing the landmarks was inherently quicker than another, the
outcome would be more reflective of the path choice taken
and less of a measure of the device itself. From careful review
of the landmark visualization order for each trial for each de-
vice, there was no significant difference for all users with each
device. This was also supported by our calculated Z variable.
We used a human stomach phantom with LED markings of
key anatomic landmarks. This model was chosen based on its
accurate anatomy, as it was created from a human patient’s
CT scan, and has ease of implementation in the outpatient clinic
setting (i. e. no need to travel to an animal lab or other facility
to perform the trials). As the model could be brought into the
outpatient clinic, the set-up and arrangement of the trial was
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in alignment with the intended location for future clinical use.
In addition, the model allowed for confounding factors such as
food, debris, mucous, and drying out of ex-vivo tissue to be a-
voided – thus ensuring that all participants “saw” the same
stomach under the same conditions. The LED markings also en-
sured that all landmarks remained in constant position for all
trials for all users, eliminating this aspect of variability between
trials. In addition, the LED markers were of ultra-low power and
provided orders of magnitude lower illumination when compar-
ed to the illumination modules in the novel endoscope or the
conventional endoscope – hence, they did not provide any
meaningful enhanced illumination for assisting the camera
module of the endoscope while completing the trials.
While the novel endoscope was designed to allow for users
to identify normal from abnormal, after a period of technical
and cognitive training, future studies will be needed to deter-
mine if users are able to definitively characterize the abnormal-
ity/pathology they have seen. thereby enhancing the novel en-
doscope’s potential clinical utility. In addition, the tip of the no-
vel endoscope is currently 13.5mm diameter due to the use of
off-the-shelf bellows (the maximum reasonable size for a pa-
tient to ingest with topical anesthetic). As a result, our team is
in the process of reducing the tip diameter to less than 8mm
for enhanced patient comfort and ease of oral intubation now
that the technology is available at the desired price point.
While we initially envision oropharyngeal intubation with a to-
pical anesthetic agent, nasopharyngeal intubation may even-
tually become a possibility through further reductions in tip
and catheter diameter.
Conclusion
In conclusion, all users were pleased with the novel endoscope.
The intuitiveness and key features of the platform have the po-
tential to allow for rapid, low-cost, diagnostic assessment of
the esophagus and stomach in non-endoscopy units or non-
ICU-based settings to facilitate patient management decisions,
minimize equipment encumbrance, and avoid cross-contami-
nation. This could facilitate patient care, potentially reduce
risk from diagnostic procedures through possible avoidance,
expedite therapeutic procedures, and improve allocation of
endoscopy resources. Planning for first-in-human trials is cur-
rently underway.
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